MEDIFAST, INC. (NYSE:MED) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
On May 4, 2017 Medifast, Inc. issued a Press Release announcing
its earnings for the first quarter ending March 31, 2017.
A copy of the Press Release is being furnished as Exhibit 99.1
attached hereto and is incorporated by reference herein. This
information is being furnished in this report and shall not be
deemed to be filed for any purpose, including for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference
into any filing under the Securities Act of 1933, as amended, or
the Exchange Act, except as shall be expressly set forth by
specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
|99.1||Press release dated May 4, 2017|
About MEDIFAST, INC. (NYSE:MED)
Medifast, Inc. (Medifast) is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and diet products. The Company operates through its subsidiaries, Jason Pharmaceuticals, Inc., Take Shape For Life, Inc., Jason Enterprises, Inc., Medifast Franchise Systems (MFSI), Inc., Jason Properties, LLC, Medifast Nutrition, Inc. and Seven Crondall, LLC. Its product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. It provides weight loss, weight management and healthy living products and programs through multiple channels of distribution: direct to consumer channel through its Website and in-house call centers; Take Shape For Life; Franchise Medifast Weight Control Centers, and a national network of physicians. It offers its products under the Medifast, Thrive by Medifast, Optimal Health by Take Shape For Life and Essential 1 brands. MEDIFAST, INC. (NYSE:MED) Recent Trading Information
MEDIFAST, INC. (NYSE:MED) closed its last trading session up +0.44 at 45.52 with 89,433 shares trading hands.